LOADING
Comparing Merck & Company (MRK) and Qualcomm Inc (QCOM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | QCOM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $298.8B | $135.4B |
| P/E Ratio | 16.6 | 25.6 |
| Forward P/E | 23.5 | 11.6 |
| PEG Ratio | 3.68 | 0.54 |
| EPS | $7.27 | $4.96 |
| Revenue Growth (YoY) | 5.0% | 5.0% |
| Profit Margin | 28.1% | 12.0% |
| Return on Equity | 36.9% | 21.5% |
| Dividend Yield | 2.68% | 2.77% |
| Beta | 0.26 | 1.27 |
| 52-Week High | $124.22 | $203.60 |
| 52-Week Low | $70.74 | $118.03 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Qualcomm Inc offers a higher dividend yield for income investors. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.